{"id":3196,"date":"2014-01-29T13:00:00","date_gmt":"2014-01-29T13:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/"},"modified":"2014-01-29T13:00:00","modified_gmt":"2014-01-29T13:00:00","slug":"xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/","title":{"rendered":"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Barnes Jewish Hospital i St Louis, som \u00e4r en pionj\u00e4r inom lungtransplantation, \u00e4r den tionde transplantationskliniken att delta i NOVEL studien. Organ Procurement Organization* (OPO) Mid-America Transplant Services har investerat i en XPS\u2122 f\u00f6r att st\u00e4rka samarbetet mellan transplantationscentra och OPO. Detta samarbete \u00e4r det andra i sitt slag i USA.<\/strong><\/div>\n<p><span>Mid-American Transplant Services investerade i en XPS\u2122 och samarbetar med Barnes &#8211; Jewish Hospital f\u00f6r att \u00f6ka utnyttjandet av lungor, vilket m\u00f6jligg\u00f6r transplantationer till fler patienter med sv\u00e5r lungsjukdom. Barnes &#8211; Jewish Hospital startade 1988, som ett av de f\u00f6rsta sjukhusen i USA, ett program helt till\u00e4gnad lungtransplantation. Lungtransplantations-programmet \u00e4r ett av v\u00e4rldens st\u00f6rsta med mer \u00e4n 1000 transplantationer utf\u00f6rda p\u00e5 vuxna patienter.<\/span><\/p>\n<p><span>NOVEL studien designades f\u00f6r att p\u00e5 ett s\u00e4kert s\u00e4tt \u00f6ka antalet anv\u00e4ndbara lungor fr\u00e5n donatorpoolen och p\u00e5g\u00e5r nu p\u00e5 10 centra i USA. I studien j\u00e4mf\u00f6rs de kliniska resultaten efter transplantation av lungor som varmperfunderats efter att initialt ha bed\u00f6mts som oanv\u00e4ndbara med en kontrollgrupp av s\u00e5dana som initialt ha bed\u00f6mts som anv\u00e4ndbara. Resultaten s\u00e5 h\u00e4r l\u00e5ngt in i studien indikerar p\u00e5 att lungor som utv\u00e4rderats med STEEN Solution\u2122 i en XPS\u2122 inte skiljer sig s\u00e4kerhetm\u00e4ssigt och funktionellt fr\u00e5n lungor som transplanterats direkt. Dessa resultat samst\u00e4mmer med de som publicerats fr\u00e5n centra i Kanada och Europa som kliniskt anv\u00e4nt STEEN Solution\u2122 med likv\u00e4rdig teknik.<\/span><\/p>\n<p><span>&#34;Vi \u00e4r glada \u00f6ver att \u00e4nnu en v\u00e4lrenommerad transplantationsklinik har g\u00e5tt med i NOVEL studien och att den anslutna OPOn har investerat i en XPS\u2122. Samarbetet \u00e4r det andra i sitt slag i USA och kommer att \u00f6ka utnyttjandet av lungor, vilket kommer ge transplantationer till fler patienter med sv\u00e5r lungsjukdom&#34; s\u00e4ger Dr. Magnus Nilsson, VD p\u00e5 XVIVO Perfusion. <\/span><\/p>\n<p><span>G\u00f6teborg 29 januari 2014<br \/> XVIVO Perfusion AB (publ)<\/span><\/p>\n<p><span>* En OPO eller Organ Procurement Organization \u00e4r ansvarig f\u00f6r samordning och utv\u00e4rdering av donerade organ f\u00f6r organtransplantation i en region i USA.<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, tel: 031-788 21 59, e-post: <a href=\"mailto:christoffer.rosenblad@xvivperfusion.com\" rel=\"nofollow\">christoffer.rosenblad@xvivoperfusion.com<\/a><br \/>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, <a href=\"http:\/\/www.xvivoperfusion.com\" rel=\"nofollow\">www.xvivoperfusion.com<\/a><\/span><\/p>\n<p><span>XVIVO Perfusion\u00a0\u00e4r skyldigt att offentligg\u00f6ra informationen i detta pressmeddelande enligt lagen om v\u00e4rdepappersmarknaden och\/eller lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r publicering den\u00a029 januari 2014 kl. 14:00.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Barnes Jewish Hospital i St Louis, som \u00e4r en pionj\u00e4r inom lungtransplantation, \u00e4r den tionde transplantationskliniken att delta i NOVEL&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3196","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Barnes Jewish Hospital i St Louis, som \u00e4r en pionj\u00e4r inom lungtransplantation, \u00e4r den tionde transplantationskliniken att delta i NOVEL...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\\\/\",\"name\":\"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2014-01-29T13:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO","og_description":"Barnes Jewish Hospital i St Louis, som \u00e4r en pionj\u00e4r inom lungtransplantation, \u00e4r den tionde transplantationskliniken att delta i NOVEL...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/","name":"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2014-01-29T13:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-usa-studien-med-ytterligare-en-ledande-transplantationsklinik\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO ut\u00f6kar USA-studien med ytterligare en ledande transplantationsklinik"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}